Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Riluzole × Gastrointestinal × Clear all

Phase

Status

Recruiting 2 Suspended 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1

Interventions

Gemcitabine 6 Bevacizumab 5 S 1 (combination) 4 Oxaliplatin 4 Irinotecan 4 Capecitabine 4 atezolizumab 3 Specimen Handling 3 Leucovorin 3 Fluorouracil 3 Drug Therapy 3 trifluridine tipiracil drug combination 2 titanium silicide 2 spartalizumab 2 lenvatinib 2 Radiotherapy 2 Nivolumab 2 Immunotherapy 2 Endoscopic Mucosal Resection 2 Cyclophosphamide 2 130-nm albumin-bound paclitaxel 2 zimberelimab 1 vactosertib 1 tucatinib 1 tivozanib 1 sotigalimab 1 sodium thiosulfate 1 rhenium-SSS-lipiodol 1 regorafenib 1 poly(I).poly(c12,U) 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03722680 2025-04-23

RILUZOX-01

UNICANCER

Phase 2 Suspended

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡